
doi: 10.1111/imj.13181
pmid: 27633469
Symptomatic cytomegalovirus (CMV) in immunocompetent individuals is an uncommon, yet recognised, phenomenon. This report discusses a case of CMV‐associated thrombocytopenia refractory to immunomodulation and antivirals. Ultimately, a clinicopathological response was attained with eltrombopag. This is the first report of the efficacy of thrombopoietin receptor agonists in this context. This experience provides insight into possible pathogenic mechanisms of CMV‐associated thrombocytopenia and presents a therapeutic option.
Purpura, Thrombocytopenic, Idiopathic, Cytomegalovirus, Middle Aged, Antiviral Agents, Benzoates, Hydrazines, Cytomegalovirus Infections, Humans, Prednisone, Pyrazoles, Female, Receptors, Thrombopoietin
Purpura, Thrombocytopenic, Idiopathic, Cytomegalovirus, Middle Aged, Antiviral Agents, Benzoates, Hydrazines, Cytomegalovirus Infections, Humans, Prednisone, Pyrazoles, Female, Receptors, Thrombopoietin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
